PositoAI/ US/ ADMA Biologics, Inc.

ADMA Biologics, Inc.

NasdaqGM: ADMA · Healthcare

Positivity Index

#4,147 / 6,775

Global

#1,987 / 4,000

United States

Positivity Score

19,883

Rank→

Overview Go Deep Penta Pattern Funda News For this company Histo

PosiRed: no active red flags

ADMA Biologics, Inc. — Overview & Financial Snapshot

ADMA Biologics, Inc. (NasdaqGM: ADMA) is a Healthcare company, ranked #4,147 of 6,775 companies globally and #1,987 of 4,000 in United States on PositoAI, with a Positivity Score of 19,883. Its market capitalisation is ₹23,150.60 Cr ($2.45B), P/E ratio is 15.6 and P/B ratio is 6.01. It has no active red flags (PosiRed) or yellow flags (PosiYellow) on record.

For financial statements, ratio trends and score history, Go Deep →

Top-ranked Healthcare companies

#3 Dogwood Therapeutics, Inc. 27,827 #8 Impact BioMedical Inc. 26,149 #13 Onconetix, Inc. 25,902 #15 Revelation Biosciences, Inc. 25,780 #18 Vyome Holdings, Inc. 25,696

— Nothing to show —

OpenAI is reading recent news...

ADMA Biologics, Inc., a biopharmaceutical company, develops, manufactures, and markets specialty plasma-derived biologics for the treatment of immune deficiencies and infectious diseases in the United States and internationally. The company operates through ADMA BioManufacturing and Plasma Collection Centers segments. The company offers BIVIGAM, an intravenous immune globulin (IVIG) product indicated for the treatment of primary humoral immunodeficiency (PI); ASCENIV, an IVIG product for the treatment of PI; and Nabi-HB, a human polyclonal antibody product for the treatment of acute exposure to blood containing Hepatitis B surface antigen and other listed exposures to Hepatitis B. It also develops a pipeline of plasma-derived therapeutics comprising products related to the methods of treatment and prevention of S. pneumonia infection for an immunoglobulin. In addition, the company operates source plasma collection facilities. The company sells its products through independent distributors, drug wholesalers, specialty pharmacies, and other alternate site providers. ADMA Biologics, Inc. was incorporated in 2004 and is headquartered in Ramsey, New Jersey.

P/B Ratio 6.01

P/E Ratio 15.6

D/E Ratio 0.50

ROE 41.90%

Owes vs Owns ? 0.40× Low $0.40 owed for every $1 it owns · balance sheet Jun 2026

Dividend Yield 0.00%

Trailing EPS ₹66.07$0.70

Forward EPS ₹89.04$0.94

Beta 0.69

Market Cap ₹23,150.60 Cr$2.45B

What these numbers mean →

What does ADMA Biologics, Inc. do?

What is ADMA Biologics, Inc.'s P/E and P/B ratio?

ADMA Biologics, Inc. has a P/E ratio of 15.6 and a P/B ratio of 6.01.

What is ADMA Biologics, Inc.'s debt-to-equity ratio?

ADMA Biologics, Inc. has a debt-to-equity ratio of 0.50.

How much does ADMA Biologics, Inc. owe compared with what it owns?

ADMA Biologics, Inc. owes $0.40 for every $1 it owns (balance sheet Jun 2026), which is low.

What is ADMA Biologics, Inc.'s Positivity rank?

ADMA Biologics, Inc. is ranked #4,147 of 6,775 companies globally and #1,987 of 4,000 in United States on PositoAI, with a Positivity Score of 19,883.

Does ADMA Biologics, Inc. have any regulatory orders, red flags (PosiRed) or yellow flags (PosiYellow)?

No active red flags (PosiRed) or yellow flags (PosiYellow) are currently on record for ADMA Biologics, Inc..

Where can I read the latest news about ADMA Biologics, Inc.?

Recent headlines about ADMA Biologics, Inc. from the last 30 days, with links to the original articles, are on its News page on PositoAI.

Does ADMA Biologics, Inc. have a PositoAI PosiShot or QR code?

Yes. A dated PosiShot of ADMA Biologics, Inc.'s current position, a PosiQR code for its live profile and a ready-made dated mention are available on its For this company page on PositoAI.

0 / 1000

🔒 Private — stored only in this browser, never sent to PositoAI. Clear anytime in Settings.